The truncated form of EPHA7 (EPHA7TR) was revealed as a soluble tumor suppressor for follicular lymphoma by inhibiting EPHA2 signaling [25], which makes EPHA7 a promising targeted therapeutic polypeptide. This evidence concerns the gene EPHA2 and neoplasm.